Quick Answer
Galmed Pharmaceuticals Ltd. reported Operating Income of -$30.21 million for fiscal year 2020.
Galmed Pharmaceuticals Ltd. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2020 | -$30.21M | -35.0% |
| 2019 | -$22.38M | -108.8% |
| 2018 | -$10.71M | +13.3% |
| 2017 | -$12.36M | — |
- Galmed Pharmaceuticals Ltd. showed a decrease of -35.0% in Operating Income compared to the prior fiscal year.
- Over the 2017–2020 period, Galmed Pharmaceuticals Ltd.’s operating income has declined by 144.3% (from -$12.36 million to -$30.21 million).
- The most recent figure is from Galmed Pharmaceuticals Ltd.’s fiscal year 2020 report (Form 20-F), filed with the SEC on March 18, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: